Cynata Therapeutics Ltd (CYP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.969x

Based on the latest financial reports, Cynata Therapeutics Ltd (CYP) has a cash flow conversion efficiency ratio of -0.969x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.79 Million ≈ $-4.10 Million USD) by net assets (AU$5.98 Million ≈ $4.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CYP days of operational coverage to measure how many days the company can operate on defensive assets alone.

Cynata Therapeutics Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Cynata Therapeutics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cynata Therapeutics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cynata Therapeutics Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SQX Resources Ltd AU:SQX	0.000x
HiteJinro Holdings Co Ltd KO:000145	-0.020x
Secure Trust Bank PLC LSE:STB	-0.575x
TOMCO ENERGY POST CON. F:NI41	N/A
Petrotal Corp LSE:PTAL	0.013x
Airtouch Solar Ltd TA:ARTS	-0.081x
Yimutian Inc. American Depositary Shares NASDAQ:YMT	0.001x
Khandwala Securities Limited NSE:KHANDSE	-0.051x

Annual Cash Flow Conversion Efficiency for Cynata Therapeutics Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Cynata Therapeutics Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Cynata Therapeutics Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$5.98 Million ≈ $4.23 Million	AU$-8.72 Million ≈ $-6.17 Million	-1.458x	-5.63%
2024-06-30	AU$7.22 Million ≈ $5.11 Million	AU$-9.96 Million ≈ $-7.05 Million	-1.380x	-61.69%
2023-06-30	AU$16.73 Million ≈ $11.84 Million	AU$-14.28 Million ≈ $-10.11 Million	-0.854x	-520.04%
2022-06-30	AU$23.96 Million ≈ $16.95 Million	AU$-3.30 Million ≈ $-2.33 Million	-0.138x	+24.35%
2021-06-30	AU$28.37 Million ≈ $20.08 Million	AU$-5.16 Million ≈ $-3.65 Million	-0.182x	+9.81%
2020-06-30	AU$16.79 Million ≈ $11.88 Million	AU$-3.39 Million ≈ $-2.40 Million	-0.202x	+67.25%
2019-06-30	AU$10.97 Million ≈ $7.76 Million	AU$-6.76 Million ≈ $-4.78 Million	-0.616x	-133.37%
2018-06-30	AU$15.39 Million ≈ $10.89 Million	AU$-4.06 Million ≈ $-2.87 Million	-0.264x	+9.59%
2017-06-30	AU$13.86 Million ≈ $9.81 Million	AU$-4.05 Million ≈ $-2.86 Million	-0.292x	+42.44%
2016-06-30	AU$8.58 Million ≈ $6.07 Million	AU$-4.35 Million ≈ $-3.08 Million	-0.507x	-70.56%
2015-06-30	AU$8.75 Million ≈ $6.19 Million	AU$-2.60 Million ≈ $-1.84 Million	-0.297x	-58.11%
2014-06-30	AU$9.85 Million ≈ $6.97 Million	AU$-1.85 Million ≈ $-1.31 Million	-0.188x	+59.64%
2013-06-30	AU$1.64 Million ≈ $1.16 Million	AU$-765.76K ≈ $-541.83K	-0.466x	+45.44%
2012-06-30	AU$853.75K ≈ $604.08K	AU$-729.33K ≈ $-516.05K	-0.854x	+68.73%
2011-06-30	AU$971.93K ≈ $687.70K	AU$-2.66 Million ≈ $-1.88 Million	-2.732x	-30.36%
2010-06-30	AU$932.00K ≈ $659.45K	AU$-1.95 Million ≈ $-1.38 Million	-2.096x	-65.58%
2009-06-30	AU$961.98K ≈ $680.66K	AU$-1.22 Million ≈ $-861.47K	-1.266x	-94.87%
2008-06-30	AU$2.21 Million ≈ $1.56 Million	AU$-1.44 Million ≈ $-1.02 Million	-0.649x	--

About Cynata Therapeutics Ltd

AU:CYP Australia Biotechnology

Market Cap

$3.02 Million

AU$4.27 Million AUD

Market Cap Rank

#29448 Global

#1694 in Australia

Share Price

AU$0.02

Change (1 day)

-93.08%

52-Week Range

AU$0.02 - AU$0.40

All Time High

AU$1.84